Advertisement

Topics

Biotecnol SA is a biotechnology company Company Profile

16:27 EST 11th December 2018 | BioPortfolio

Biotecnol SA is a biotechnology company focused on the development of biopharmaceutical products. Biotecnol has a special focus on the development of antibody-based therapeutics to treat life-threatening diseases such as cancer

Location

Empreendimento Lagoas ParkEdifício 7 - 1º Piso Norte
Porto Salvo
Oeiras
2741-901
Portugal

Contact

Phone: 351 214220520
Fax: 351 214220529
Email: biotecnol@biotecnol.com


News Articles [216 Associated News Articles listed on BioPortfolio]

The Diversification of Biotecnol

Biotecnol is proof that a hybrid business model works. As its CEO, Pedro de Noronha Pissarra, explains in this interview, the revenue stream created by its contract research and manufacturing arm not ...

Neill Moray Mackenzie, Biotecnol: Immunotherapies for Life™

Biotecnol is working in the field of immuno-oncology and is using proprietary antibody-based technologies to engineer and develop highly- targeted therapeutic products which utilize a patient’s own ...

Biotecnol Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryBiotecnol Ltd Biotecnol is a biopharmaceutical company that develops antibodybased therapeutics for the treatment of diseases in various therapeutic areas and indications. The company develops ...

Biotecnol Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13042018] Prices from USD $250

SummaryBiotecnol Ltd Biotecnol is a biopharmaceutical company that develops antibodybased therapeutics for the treatment of diseases in various therapeutic areas and indications. The company develops ...

Biotecnol Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11072018] Prices from USD $250

SummaryBiotecnol Ltd Biotecnol is a biopharmaceutical company that develops antibodybased therapeutics for the treatment of diseases in various therapeutic areas and indications. The company develops ...

Puma Biotechnology to Present at Jefferies Global Healthcare Conference

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provi...

What’s the Deal with Longevity Company Unity Biotechnology and its $700 Million Valuation?

Unity Biotechnology has raised $222 million in venture capital, raised $85 million in an initial public offering (IPO) in May, and has a value of $700 million. All without having a product to sell.

Puma Biotechnology to Present at Cantor Global Healthcare Conference

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provi...

PubMed Articles [256 Associated PubMed Articles listed on BioPortfolio]

Characteristics of Occupational Injuries in a Pharmaceutical Company in Iran.

To prioritize occupational hazards in a Pharmaceutical Company in Iran using the analytical hierarchy process (AHP).

A Man (or a Woman) is Known by the Company He/She Keeps.

Biotechnology in Europe: A Challenge for Central and East European Countries.

Risk Assessment of Processes and Products in Industrial Biotechnology.

Risk assessment has been used extensively as the main approach to prevent accidents in the chemical and process industry. Industrial biotechnology has many of the same hazards as chemical technology, ...

Asian Congress on Biotechnology 2017.

Clinical Trials [90 Associated Clinical Trials listed on BioPortfolio]

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult Subjects

- Objective: - A Randomized, Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Co...

A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants

In order to evaluate immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine produced by Beijing Minhai Biotechnology Co., Ltd., a randomized, double-blind, parallel-contro...

Companies [2575 Associated Companies listed on BioPortfolio]

Biotecnol SA is a biotechnology company

Biotecnol SA is a biotechnology company focused on the development of biopharmaceutical products. Biotecnol has a special focus on the development of antibody-based therapeutics to treat ...

China Dasheng Biotechnology Company

China Dasheng Biotechnology Company, a leading producer and distributor of organic bacteria based additives for crops and livestock feeds through its three subsidiary segments, Gansu Dasheng Biote...

AVAX Technologies, Inc.

AVAX Technologies, Inc. is a biotechnology company with operations in the United States and Europe. The Company is engaged in the research, clinical and commercial development of ...

Yongye Biotechnology International, Inc.

Yongye Biotechnology International, Inc., headquartered in Beijing, is engaged in the development, distribution and sales of Shengmingsu brand plant and animal nutrient products. The Company's pat...

BioSystems S.A

BioSystems S.A. es una compañía íntegramente financiada por capitales argentinos. Su área de acción incluye asesoramiento y planificación en la instalación de equipos e insumos en laboratorios ...

More Information about "Biotecnol SA is a biotechnology company" on BioPortfolio

We have published hundreds of Biotecnol SA is a biotechnology company news stories on BioPortfolio along with dozens of Biotecnol SA is a biotechnology company Clinical Trials and PubMed Articles about Biotecnol SA is a biotechnology company for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biotecnol SA is a biotechnology company Companies in our database. You can also find out about relevant Biotecnol SA is a biotechnology company Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record